Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aurobindo Settles Dispute With Plethico Over Natrol Fraud Charges

This article was originally published in PharmAsia News

Executive Summary

Last year Aurobindo acquired Plethico’s Natrol dietary supplements business in the U.S., which was divested as part of court-directed bankruptcy proceedings. A few months on, the Hyderabad-based drug maker filed a case charging the seller of perpetrating fraud. Aurobindo has now informed Indian stock exchanges that it agreed to settle the matter in return for certain cash payments and transfer of assets from Plethico.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts